What is the effect of Xinkeshu tablets added to usual treatment on the function of the circulatory system in patients with coronary artery disease and high blood pressure?
Not Applicable
Completed
- Conditions
- Coronary heart disease combined with hypertension and vascular dysfunctionCirculatory System
- Registration Number
- ISRCTN22691979
- Lead Sponsor
- Shandong Wohua Pharmaceutical Co Ltd
- Brief Summary
2021 Results article in https://doi.org/10.1155/2021/5561272 (added 28/03/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
1. Aged 18-70 years
2. Diagnosed with hypertension and coronary artery disease and have received regular coronary heart disease secondary prevention drugs and antihypertensive drugs
3. Baseline GAD-7 and PHQ-9 score were both between 5-14 points
4. Have given written informed consent prior to study participation
Exclusion Criteria
1. Severe liver or kidney dysfunction or malignant tumors
2. Allergic to any component of Xinkeshu tablet
3. Cardiovascular or cerebrovascular accident within previous 3 months
4. Pregnant or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method